| [1] |
.
[J]. Clinical Focus, 2023, 38(5): 477-480.
|
| [2] |
Feng Jue.
Correct diagnosis and standardized treatment of Graves' hyperthyroidism
[J]. Clinical Focus, 2016, 31(3): 233-236.
|
| [3] |
Zhang Lihui, Yuan Lingling.
Progress in diagnosis and treatment of subclinical hyperthyroidism
[J]. Clinical Focus, 2016, 31(3): 237-240.
|
| [4] |
Lu Xiaowei, Zhou Hong.
Diagnosis and treatment in Graves’ ophthalmopathy
[J]. Clinical Focus, 2016, 31(3): 241-245.
|
| [5] |
Zhang Rongjin,Hao Yongmei.
Pathogenesis and treatment of patients with Graves disease presenting with leucopenia or agranulocytosis
[J]. Clinical Focus, 2016, 31(3): 246-249.
|
| [6] |
Li Hui,Li Jing.
Recent progress in treatment of anti-thyroid drugs on pregnant women with hyperthyroidism
[J]. Clinical Focus, 2016, 31(3): 254-257.
|
| [7] |
Liu Zhihong,Wang Ruiying.
Influence of pregnancy hyperthyroidism on offspring brain development
[J]. Clinical Focus, 2016, 31(3): 258-261.
|
| [8] |
Wang Yong;Ding Yong;Xing Jialiu;Zhang Youren;Guan Meichao.
Bone mineral density change in hyperthyroidism patients before and after 131 I treatment
[J]. Clinical Focus, 2015, 30(1): 74-77.
|
| [9] |
.
@@
[J]. Clinical Focus, 2014, 29(10): 1198-1200.
|
| [10] |
HE Ke;HU Yun;GUO Mu-hong;MAO Xiao-ming.
Thyrotropin receptor antibody induced-apoptosis and proliferation in human hepatoma HepG2 cells
[J]. Clinical Focus, 2014, 29(1): 45-48.
|
| [11] |
.
[J]. CLINICAL FOCUS, 2013, 28(12): 1411-1412.
|
| [12] |
.
[J]. CLINICAL FOCUS, 2013, 28(10): 1141-1142.
|
| [13] |
.
[J]. CLINICAL FOCUS, 2013, 28(10): 1143-1144.
|
| [14] |
WANG Yan-fang;DING Chang-xia;LIU Cun-jie;ZHAO Hai-yun;LI Chong;ZHANG Xiu-li;HAN Hong-wei.
Intracranial atherosclerotic changes ofdoi:ents with hyperthyroidism by transcranial Doppler ultrasound and carotid ultrasonography
[J]. CLINICAL FOCUS, 2013, 28(8): 844-847.
|
| [15] |
.
[J]. CLINICAL FOCUS, 2013, 28(3): 306-307.
|
